Portman Square Capital LLP Bridge Bio Pharma, Inc. Put Options Transaction History

Portman Square Capital LLP

  • $2.72 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Jul 19, 2024
SELL
$23.0 - $31.04 $10.5 Million - $14.2 Million
-457,400 Reduced 65.66%
239,200 $6.06 Million
Q1 2024

Apr 15, 2024
SELL
$27.35 - $40.45 $2.93 Million - $4.34 Million
-107,200 Reduced 13.34%
696,600 $21.5 Million
Q4 2023

Jan 19, 2024
SELL
$24.02 - $43.89 $1.92 Million - $3.51 Million
-80,000 Reduced 9.05%
803,800 $32.4 Million
Q3 2023

Oct 30, 2023
BUY
$16.89 - $35.01 $14.9 Million - $30.9 Million
883,800 New
883,800 $23.3 Million

Others Institutions Holding BBIO

# of Institutions
288
Shares Held
170M
Call Options Held
7.64M
Put Options Held
2.15M
View Full List

About BridgeBio Pharma, Inc.

BBIO Quotes by TradingView
  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $3.88B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Portman Square Capital LLP Portfolio

Follow Portman Square Capital LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portman Square Capital LLP, based on Form 13F filings with the SEC.

News

Stay updated on Portman Square Capital LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email